ABCG2 protein expression in tumors of patients with non-resectable pancreatic cancer treated with gemcitabine and nab-paclitaxel
BackgroundATP-binding cassette (ABC) proteins are transmembrane efflux pumps that play a role in Multi Drug Resistance. ABCG2 and ABCB1 have been suggested as important mediators of resistance to chemotherapy (CTx) in pancreatic cancer (PC). We determined the expression of ABCG2 and ABCB1 proteins i...
Saved in:
| Main Authors: | Susy Shim, Mette Bak Nielsen, Mikkel Eld, Jan Stenvang, Rasmus Froberg Brøndum, Britta Weber, Anne Krejbjerg Motavaf, Morten Ladekarl |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1558184/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nab-Paclitaxel plus gemcitabine in patients with metastatic pancreatic adenocarcinoma: experience of use
by: Elena Ferris Villanueva, et al.
Published: (2015-02-01) -
Cost-effectiveness of NALIRIFOX versus Nab-paclitaxel and gemcitabine in previously untreated metastatic pancreatic ductal adenocarcinoma
by: Wenjie Liu, et al.
Published: (2025-04-01) -
Reversal of ABCG2-mediated drug resistance by tinodasertib (ETC-206)
by: Haigan Yang, et al.
Published: (2025-06-01) -
Correction: Reversal of ABCG2-mediated drug resistance by tinodasertib (ETC-206)
by: Haigan Yang, et al.
Published: (2025-08-01) -
Association of <i>ABCG5</i> and <i>ABCG8</i> Polymorphisms with Gallstone Disease and Gallbladder Cancer
by: I. N. Grigor’eva, et al.
Published: (2025-06-01)